Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07299513

Aerodigestive Fistulas in Adults at the University Hospital of Strasbourg

Acquired aerodigestive fistulas in adults are rare conditions, corresponding to a pathological communication between the digestive and respiratory tracts, requiring collaborative multidisciplinary management. Clinical manifestations are nonspecific, ranging from a simple cough to pulmonary sepsis, which can be life-threatening. Diagnosis is often multimodal, requiring radiological examinations and endoscopic investigations. The most frequent etiologies are divided into two groups: benign and malignant causes, each group representing 50% of all acquired aerodigestive fistulas. Among the benign etiologies, 75% are iatrogenic, mainly represented by complications related to orotracheal intubation. These fistulas of benign etiology most often have a favorable prognosis, amenable to surgical treatment. Conversely, the development of an aerodigestive fistula in the context of thoracic cancer marks a turning point in the evolution of the oncological disease. Indeed, the average life expectancy of patients with a malignant fistula is estimated at between 1 and 6 weeks without specific treatment. Following this palliative approach aimed at improving quality of life, multiple treatment options are available, often combined with digestive and thoracic endoscopy.

The Strasbourg University Hospitals are a leading tertiary care center for these pathologies, with departments of Pulmonology, Gastroenterology, Digestive Surgery, Thoracic Surgery, Medical Intensive Care, Multipurpose Surgical Intensive Care, Bronchial Endoscopy, and Digestive Endoscopy. The centre's influence extends over the entire eastern part of the Grand Est region (Nancy, Metz, Strasbourg, Mulhouse).

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Service de Pneumologie - Hôpitaux Universitaires de Strasbourg

Strasbourg, 67091, France

Location status: Recruiting

Location contact

Arnaud SIEGEL, MD

SUB_INVESTIGATOR

Guillaume PAMART, MD

CONTACT

[email protected]

33 3/69/55/06/48

Guillaume PAMART, MD

PRINCIPAL_INVESTIGATOR

Julien GODET, Statistician

SUB_INVESTIGATOR

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age > 18 years at diagnosis
  • Diagnosis between January 1, 2014, and December 31, 2023
  • Aerodigestive fistula defined by one of the following criteria:
  • Fistula visualized by bronchoscopy and/or digestive endoscopy
  • Fistula visualized by static chest imaging (CT scan or MRI)
  • Fistula visualized by dynamic chest imaging (barium swallow)
  • Hospitalization at the Strasbourg University Hospitals (HUS)

Exclusion criteria

  • Explicit refusal by the patient to provide their data

Treatment and study plan

Primary outcomes

  1. Overall survival rate since diagnosis

    Time frame: Up to 2 years

Study contacts

Contact information is provided by the study sponsor or research team.

Guillaume PAMART, MD

CONTACT

[email protected]

33 3/69/55/06/48

Sponsors and collaborators

Lead sponsor

University Hospital, Strasbourg, France

Other

Registry information

Official study title

Aerodigestive Fistulas in Adults: Management at the Strasbourg University Hospital Between 2014 and 2023

Acronym: FAD'HUS

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
Dec 23, 2025
Registry last updated
Dec 23, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.